Cargando…
Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway
Hepatocellular carcinoma (HCC) is a devastating and highly metastatic cancer worldwide. Metformin (MET) is the priority drug for treatment of type 2 diabetes; however, it possesses multiple biological effects like anticancer and hepatoprotective activity. Herein, we examined the effects of aloin (ba...
Autores principales: | Sun, Ruijie, Zhai, Ruiren, Ma, Changlin, Miao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997051/ https://www.ncbi.nlm.nih.gov/pubmed/31830378 http://dx.doi.org/10.1002/cam4.2723 |
Ejemplares similares
-
Ivermectin induces autophagy-mediated cell death through the AKT/mTOR signaling pathway in glioma cells
por: Liu, Jingjing, et al.
Publicado: (2019) -
Metformin induces degradation of mTOR protein in breast cancer cells
por: Alalem, Mohamed, et al.
Publicado: (2016) -
mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development
por: Feng, Jing, et al.
Publicado: (2020) -
Puerarin 6″‐O‐xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR
por: Li, Long, et al.
Publicado: (2020) -
CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5‐FU‐induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway
por: Sun, Yi, et al.
Publicado: (2017)